Our Latest Thinking on Biopharmaceuticals

The biotech and pharma industries continue their fast-paced digital evolution, while geopolitical and economic forces present hurdles that require a fine-tuned strategy throughout the supply chain. Explore BCG’s latest thought leadership on biopharmaceuticals for key insights into the future of the life sciences industry.

Featured Insights

COVID-19

plan-effective-covid-19-response-rectangle-tcm9-243582.jpg

PLAN for an Effective COVID-19 Response

Preparing Localities for Action Against Novel Coronavirus (PLAN) is a scenario-planning tool that identifies potential US supply and demand imbalances down to the county level.

Strategy

Digital & Analytics

covid19-green-interrupter-gradient-tcm9-240912.jpg

COVID-19 and the New Leadership Agenda

The COVID-19 outbreak underscores the need to be resilient in the face of transformative global risk.

Commercial

Diversity

Operations

What-is-Next-for-CDMOs-After-COVID-19-rectangle.jpg

What’s Next for CDMOs After COVID-19?

The soaring demand for COVID-19 vaccines provides an opportunity for contract manufacturers to deepen their relationships with biopharmaceutical customers and drive growth.

Research & Development

car-t-2880x1620-tcm9-195772.jpg

Placing Your CAR-T Bets

These new therapies are poised to revolutionize oncology. It all depends on reaching a larger patient base and simplifying manufacturing and the supply chain.

Anticipating the Spread of COVID-19 with Scenario Planning

Anticipating the Spread of COVID-19 with Scenario Planning

Anticipating the Spread of COVID-19 with Scenario Planning

Accelerating Drug Development Today

Accelerating Drug Development Today

How to Lead a Digital Transformation: By Internal Disruption

How to Lead a Digital Transformation: By Internal Disruption

BCG GAMMA's Transformative Work for an Oncology Center

BCG GAMMA's Transformative Work for an Oncology Center

Using Big Data to Help Fight Cancer

Using Big Data to Help Fight Cancer

Innovation in Biopharma R&D

Innovation in Biopharma R&D

ted-michael-ringel-milan-tcm9-179594.png

Les basiques de l’innovation externe par un expert en R&D

Karalee Close on The Digital Opportunity in Healthcare

Karalee Close on The Digital Opportunity in Healthcare

Frank Cordes on The Pharma Factory of the Future

Frank Cordes on The Pharma Factory of the Future

Mark Lubkeman on A Return to Growth

Mark Lubkeman on A Return to Growth

Biopharmaceuticals

SUBSCRIBE